-
Product Insights
Opioid-Induced Constipation (OIC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Opioids are effective pain relievers, but often have the side effect of constipation. These medicines affect the gastrointestinal tract in a variety of ways. Opioids increase the amount of time it takes stool to move through the gastric system. They increase non-propulsive contractions in the middle of the small intestine (jejunum) and decrease longitudinal propulsive peristalsis - motions critical to moving food through the intestines. Additionally, opioids reduce digestive secretions and decrease the urge to defecate. Symptoms of Opioid-Induced Constipation...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for December 2017 in Pharmaceuticals
The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in December 2017. The industry reported 375 deals worth USD21 billion in December 2017, compared to 403 deals worth USD27.5 billion in November 2017. The oncology therapeutics market remained at the top in deal activity in December 2017 with 124 deals. In second place, central nervous system therapeutics market reported 77 deals. Licensing agreements in pharmaceutical and healthcare industry registered an increase in upfront...
-
Product Insights
Atrophy Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Atrophy Global Clinical Trials Review, H1, 2017" provides an overview of Atrophy clinical trials scenario. This report provides top line data relating to the clinical trials on Atrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Constipation Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Constipation Global Clinical Trials Review, H1, 2017" provides an overview of Constipation clinical trials scenario. This report provides top line data relating to the clinical trials on Constipation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Track & Monitor
PharmSource – M&A in the Contract Manufacturing Industry: Implications and Outlook – 2018 Edition
This report is the 2nd edition of our analysis of Mergers and Acquisitions in the contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.
-
Sector Analysis
Competitor Landscape: Non-alcoholic Steatohepatitis (NASH)
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the NASH market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Product Insights
Constipation Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Constipation Global Clinical Trials Review, H2, 2016" provides an overview of Constipation clinical trials scenario. This report provides top line data relating to the clinical trials on Constipation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Irritable Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Irritable Bowel Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
PharmaPoint: Irritable Bowel Syndrome(IBS) – Global Drug Forecast and Market Analysis to 2026
Irritable bowel syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. IBS is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least three months. IBS is classified into three main subtypes, according to the predominant bowel habit: constipation-predominant (IBS-C), diarrhea-predominant (IBS-D), and mixed-presentation (IBS-M) IBS. The IBS treatment landscape remains largely underserved, and ample opportunity exists for pharmaceutical companies to address the...
-
Product Insights
Portal Hypertension Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Portal Hypertension Global Clinical Trials Review, H1, 2016" provides an overview of Portal Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Portal Hypertension. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...